Trial intelligence / Profile preview

Niclosamide in metastatic colorectal cancer (Nikolo)

NCT02519582Phase 2Unknown

Sponsor
Charité – Universitätsmedizin Berlin
Start
Aug 2015
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of niclosamide in colorectal cancer (CRC), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.

02

Drugs

niclosamide
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT02519582.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02519582.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call